NTRODUCTION: IWMI is associated with increased risk of death, shock, ventricular tachycardia or fibrillation and atrioventricular block (AVB), and a higher mortality rate for the first month post MI in patients with RVMI. AIMS & OBJECTIVES: To study the complications and in-hospital mortality in IWMI with RVMI. MATERIALS AND METHODS: A total of 100 patients of IWMI were recruited and screened for RVMI and complications and in-hospital mortality was recorded. RESULTS; It was observed that patients with IWMI had CHD, more commonly in RVI (7.14%) as compared with NRVI group (1.38%). Bradyarrhythmia was found in 7 cases (25%) in RVI group as compared to 3 (4.16%) in NRVI group which was statistically significant. (p= 0.002). A high mortality of 10.71% was observed in RVI group as compared to 2.77% in NRVI group (p= 0.05). DISCUSSION: In the present study, prevalence of CHB and second-degree AV block was found to be 4% and 3%, respectively, among patients with IWMI, which is lower than earlier studies. In the present study, 1 patient presented with cardiogenic shock, in each group of IWMI. In our study, total in-hospital mortality in IWMI was found to be 5%, which is less than reported prevalence. CONCLUSION: RVMI in IWMI is associated with some increased complications especially high degree AV block and CHB which harbour increased mortality. Keywords: Right Ventricular Myocardial Infarction (RVMI), Inferior Wall Myocardial Infarction (IWMI), Atrioventricular block (AVB), Complete Heart Block (CHB), Right Ventricular Infarction (RVI). Non Right Ventricular Infarction (NRVI).
Introduction: Following cardiac surgery, complications such as cardiac, pulmonary, renal, and neurological diseases, infections like pneumonia or sepsis, and extended stays in the intensive care unit (ICU) and hospital are signs of both the quality of care and the quality of life. Therefore, it's critical to pinpoint the complications that put patients at risk for substantial postoperative morbidity and extended lengths of hospital stay. Aims & Objectives: To study nature and incidence of perioperative complications in patients undergoing cardiac surgery under cardiopulmonary bypass. Material & Methods: This study included 151 patients, of any age, either sex, planned for cardiac surgery under cardiopulmonary bypass (like Valve replacement, valve repairs, CABG, myxoma excision, Congenital Heart Diseases like ASD, VSD, TOF). The data regarding demographic profile and postoperative complications were collected. RESULTS; There were total of 151 patients in our study including 66 males (43.7%) and 85 females (56.3%). Age of the subjects ranged from 1 to 70 years with a mean of 26.39 ± 18.67 years (Median of 25 years). Mean age of males was 26.27 ± 20.72 years and mean age of females was 26.49 ± 17.03 years. About 51 % patients in our study had at least one of the complications. The most common complication was rhythm disorder which was present in 34.4% of all patients. ARDS developed in 1.3% of patients. Infections were present in 27 patients (17.9%). Dyselectrolytemia was present in 11 patients (7.3%). Conclusion: Cardiac surgery under cardiopulmonary bypass is associated with as cardiac, pulmonary, renal, and neurological diseases, infections like pneumonia or sepsis. The most common complication was rhythm disorder which was present in 34.4% of all patients. ARDS developed in 1.3% of patients. Infections were present in 27 patients (17.9%). Dyselectrolytemia was present in 11 patients (7.3%). Keywords: Cardiopulmonary Bypass (CPB), Length of stay (LOS).
INTRODUCTION: After open heart surgery (OHS) using cardiopulmonary bypass (CPB), abnormalities in the circulating thyroid hormone levels are found in the absence of primary thyroid disease; this is collectively called the sick euthyroid syndrome (SES). AIMS ANDOBJECTIVES: To study thyroid function test in patients planned for cardiac surgery under cardiopulmonary bypass. MATERIALS AND METHODS: This study included a total of 150 patients, of any age, either sex, planned for cardiac surgery under cardiopulmonary bypass (like Valve replacement, CABG, myxoma excision, congenital Heart Diseases like ASD, VSD, TOF). To assess the levels of thyroid hormone, TSH, TT3 and TT4 were measured. The blood samples were collected at regular intervals: preoperatively, on 2nd postoperative day and on 7th postoperative day. CONCLUSION: In our study the levels of thyroid hormone (TT4 and TT3) decreased significantly after cardiopulmonary bypass. Keywords: Open Heart Surgery (OHS), Cardiopulmonary Bypass (CPB), Sick Euthyroid Syndrome (SES)
INTRODUCTION: In CAP patients, the mortality rate within 90 days after discharge can be as high as 14% (this is in addition to the inpatient mortality referred to early) and considerably higher than in the general population or in those hospitalized for other reasons. However, the mortality & morbidity data in young patients of CAP (≤60 years) is sparse, this is the reason for undertaking this study. AIMS & OBJECTIVES: To study the 90 day mortality /morbidity and complications in young patients of CAP (≤60 years). MATERIALS & METHODS: 100 cases, 60 years old or younger, who were diagnosed as CAP (defined as pneumonia identified 48 hours or less from hospitalization) were studied for morbidity (complications and/or ≥10 days hospital admission and/or admission to ICU) and the 90-day mortality was calculated. RESULTS: Sepsis was significantly present in complicated hospitalisations (p value <.001). Also CCF (p value =.002) and shock (p value=.023) were significantly present in complicated group. Elevated CURB SCORE (≥2) and PSI (≥2) were significantly associated with 90 day mortality and present in complicated hospitalisation compared to uncomplicated ones. CONCLUSIONS: Young patients with CAP who had higher CURB/PSI score had higher mortality and morbidity. Also patients in complicated hospitalisation group had higher rate of associated complications and vice versa. Keywords: Community Acquired Pneumonia, CURB-65, Pneumonia severity Index (PSI).
INTRODUCTION: Symptoms of hypothyroidism are often subtle and are easily overlooked specially in patients with a heart disease and symptoms are thought to be from the existing cardiac condition. There is a consensus that patients with known hypothyroidism should have thyroid screening before any major surgery including cardiac surgery and if indicated should be made euthyroid before surgery. AIMS AND OBJECTIVES: To study the correlation of thyroid function test status with postoperative course and outcome (total duration of hospital, duration of ICU stay, hours of mechanical ventilation and in hospital mortality). MATERIAL AND METHODS: This prospective study recruited 151 patients who underwent cardiac surgery under cardiopulmonary bypass, TSH was measured and compared with outcome in these patients. RESULTS: Hours of mechanical ventilation (35.20 ± 20.1 Vs 110.61 ± 71.9 hours), ICU stay (3.3 ± 2.30 vs 5.9 ± 5.56 days) and hospital stay (16.7±4.21 days vs 21.1 ± 6.95 days) was significantly less in euthyroid than patients whose TSH was raised before surgery , also postoperative in hospital mortality was more in patients with raised TSH preoperatively. CONCLUSION: We concluded that patients with Subclinical hypothyroidism (SCHT) and Overt Hypothyroidism (OH) planned for cardiac surgery on cardiopulmonary bypass should be treated and those on levothyroxine replacement should have fair control before undergoing surgery. Keywords: Subclinical Hypothyroidism [SCHT], Overt Hypothyroidism [OH], Cardiopulmonary Bypass, Atrial Fibrillation [AF].
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.